Corticosurrénalome virilisant à cellules oncocytaires : résultats cliniques, hormonaux et immuno-histochimiques
J. Carre(Hôpital Larrey), Philip Caron(Hôpital Larrey), Catherine Mazerolles(Centre Hospitalier Universitaire de Toulouse), M. Thoulouzan(Hôpital Rangueil), Delphine Vezzosi(Université Toulouse III - Paul Sabatier), Solange Grunenwald(Hôpital Larrey), Geri Méduri(Université Paris-Sud), A. Bennet
Cited by 0
Related Papers
Constitutive Activation of PKA Catalytic Subunit in Adrenal Cushing's Syndrome
|New England Journal of Medicine|2014|434
Ketoconazole in Cushing's Disease: Is It Worth a Try?
|The Journal of Clinical Endocrinology & Metabolism|2014|288
Periprostatic adipocytes act as a driving force for prostate cancer progression in obesity
|Nature Communications|2016|287
Prognostic factors in stage III–IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study
|Annals of Oncology|2015|257
Sphingosine Kinase-1 as a Chemotherapy Sensor in Prostate Adenocarcinoma Cell and Mouse Models
|Cancer Research|2005|203